Clinical Implications of Next-Generation Sequencing for Cancer Medicine
Excerpt
In 1976, Peter Nowell, following observations of cytogenetic heterogeneity in a population of cancer-ous cells, proposed that this genetic diversity could be explained by hypothesizing that these cells are subject to evolutionary forces[...]
Share and Cite
Shuen, A.; Foulkes, W.D. Clinical Implications of Next-Generation Sequencing for Cancer Medicine. Curr. Oncol. 2010, 17, 39-42. https://doi.org/10.3747/co.v17i5.630
Shuen A, Foulkes WD. Clinical Implications of Next-Generation Sequencing for Cancer Medicine. Current Oncology. 2010; 17(5):39-42. https://doi.org/10.3747/co.v17i5.630
Chicago/Turabian StyleShuen, A., and W. D. Foulkes. 2010. "Clinical Implications of Next-Generation Sequencing for Cancer Medicine" Current Oncology 17, no. 5: 39-42. https://doi.org/10.3747/co.v17i5.630